Campbell & Co Investment Adviser’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,240
| Closed | -$103K | – | 1206 |
|
|
2025
Q1 | $103K | Buy |
+21,240
| New | +$103K | 0.01% | 984 |
|
|
2024
Q4 | – | Sell |
-47,717
| Closed | -$398K | – | 1124 |
|
|
2024
Q3 | $398K | Buy |
+47,717
| New | +$398K | 0.03% | 802 |
|
|
2023
Q3 | – | Sell |
-16,272
| Closed | -$120K | – | 1004 |
|
|
2023
Q2 | $120K | Buy |
+16,272
| New | +$120K | 0.02% | 837 |
|
|
2022
Q1 | – | Sell |
-5,050
| Closed | -$220K | – | 744 |
|
|
2021
Q4 | $220K | Sell |
5,050
-2,900
| -36% | -$126K | 0.08% | 502 |
|
|
2021
Q3 | $398K | Buy |
+7,950
| New | +$398K | 0.13% | 286 |
|
|
2019
Q4 | – | Sell |
-8,311
| Closed | -$434K | – | 689 |
|
|
2019
Q3 | $434K | Buy |
+8,311
| New | +$434K | 0.16% | 228 |
|
|
2017
Q1 | – | Sell |
-6,434
| Closed | -$211K | – | 167 |
|
|
2016
Q4 | $211K | Buy |
+6,434
| New | +$211K | 0.65% | 85 |
|